Home » Topics » BioWorld Science

BioWorld Science
RSS

Fasinumab topline phase III data presented in patients with chronic pain from OA of the knee or hip

Aug. 17, 2018

Principia Biopharma patents proteasome subunit beta type-8/beta type-9 inhibitors

Aug. 17, 2018

Sihuan Pharmaceutical begins phase II study of pirotinib

Aug. 17, 2018

Development of novel broad coverage human papilloma virus vaccines

Aug. 17, 2018

Metabolism targeting compound kills brain tumor cells

Aug. 17, 2018

Release of phase IIa clinical data concerning a first-in-class drug for type 2 diabetes treatment

Aug. 17, 2018

First patient dosed in Inovio's phase I/II study of Pennvax-GP

Aug. 17, 2018

Targeted drug delivery using humanized Sialyl Tn-specific antibodies for ovarian cancer treatment

Aug. 17, 2018

MicroRNA affects neuropathic pain

Aug. 17, 2018

To sleep, perchance to reshape your transcriptome

Aug. 17, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...